# Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism

> **NCT02977013** · — · COMPLETED · sponsor: **Mohamed Sayed Mohamed Abbas** · enrollment: 42 (actual)

## Conditions studied

- Anti-Xa Assay in Pulmonary Embolism

## Interventions

- **DIAGNOSTIC_TEST:** Anti-Xa assay

## Key facts

- **NCT ID:** NCT02977013
- **Lead sponsor:** Mohamed Sayed Mohamed Abbas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02977013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02977013, "Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02977013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*